You are here

funding

Triveni Bio's $115M haul ramps up push for precision I&I therapies

First Word Pharma

Wed, 10/2/24 - 09:43 am

Kailera launches with $400M series A and clutch of Chinese obesity drugs

Fierce Biotech

Tue, 10/1/24 - 09:57 am

Kailera Therapuetics

Cerevel Therapeutics

Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B

Fierce Biotech

Mon, 09/30/24 - 09:40 am

radiopharmaceuticals

Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science

BioPharma Dive

Thu, 09/26/24 - 11:15 am

Arch Venture Partners

Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic

Yahoo Finance

Wed, 09/25/24 - 11:58 am

Aptadir going after cancer, genetic diseases with new class of RNA inhibitors

First Word Pharma

Tue, 09/24/24 - 11:42 am

Aptadir Thrapeutics

RNA therapeutics

Startup Vicebio banks $100M in bid to make ‘cost-effective’ vaccines

BioPharma Dive

Mon, 09/23/24 - 10:24 pm

Cercle secures $6M seed fundraise to advance women’s healthcare

Businesswire

Thu, 09/19/24 - 09:27 am

artificial intelligence

Valneva Launches 60M Euro Share Placement for Vaccine Development

Tip Ranks

Fri, 09/13/24 - 11:06 am

chikungunya virus

J&J leads $50M financing for imaging company Spectrawave

Medtech Dive

Thu, 09/12/24 - 10:20 am

Medical Imaging

venture capital

Radiant Bio closes $35 million Series A funding for antibody platform

Citybiz

Wed, 09/11/24 - 11:48 am

antibody platform

With $3B funding round, Bain set to make more biotech bets

Fierce Biotech

Tue, 09/10/24 - 04:30 pm

Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease

BioPharma Dive

Mon, 09/9/24 - 10:56 am

Candid Therapeutics

autoimmune disease

Lilly-backed Superluminal raises $120M series A to bring membrane receptor drugs into the clinic

Fierce Biotech

Mon, 09/9/24 - 10:46 am

Superluminal Medicines

small molecule drugs

OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders

Businesswire

Fri, 09/6/24 - 10:50 am

ArsenalBio raises $325M in one of the year’s largest biotech funding rounds

BioPharma Dive

Wed, 09/4/24 - 11:46 am

Bristol Myers Squibb

Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain

Fierce Biotech

Fri, 08/23/24 - 11:25 am

venture capital

Illumina Ventures seeks $300m for third fund

Global Venturing

Fri, 08/23/24 - 11:05 am

Illumina Ventures

venture capital

Ambrosia lands $16m to ‘improve on existing GLP-1 drugs’

Longevity Technology

Wed, 08/21/24 - 11:26 am

Ambrosia Biosciences

Array Biopharma

BridgeBio contributes rare disease assets to $300M-backed GondolaBio venture

First Word Pharma

Wed, 08/21/24 - 11:22 am

erythropoietic protoporphyria

Pages